Details for New Drug Application (NDA): 088814
✉ Email this page to a colleague
NDA 088814 describes PROMETHAZINE W/ CODEINE, which is a drug marketed by Cenci and is included in one NDA. Additional details are available on the PROMETHAZINE W/ CODEINE profile page.
The generic ingredient in PROMETHAZINE W/ CODEINE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
The generic ingredient in PROMETHAZINE W/ CODEINE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
Summary for 088814
| Tradename: | PROMETHAZINE W/ CODEINE |
| Applicant: | Cenci |
| Ingredient: | codeine phosphate; promethazine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 10MG/5ML;6.25MG/5ML | ||||
| Approval Date: | Nov 22, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
